Investigates phenotypes in chronic limb-threatening ischemia, highlighting treatment implications.
Despite 90% procedural success, one-year amputation after peripheral artery disease (PAD) revascularization exceeds 20%.Current management treats PAD as uniform atherosclerosis, but distinct biological phenotypes determine outcomes.Diabetes causes inflammatory intimal occlusion with microangiopathy; chronic kidney disease produces medial calcification creating rigid arteries despite patent lumens.These mechanisms coexist in 35-50% of chronic limb-threatening ischemia patients.Lesion-centric approaches fail because angiographic patency does not ensure tissue healing when vascular biology remains pathologic.We propose phenotype-guided management aligning revascularization, diagnostics, and metabolic therapy with underlying pathophysiology to explain why technical success still fails to prevent amputation.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: